At the recent meeting of the PMRG Institute, Richard Vanderveer, Ph.D., Strategic Advisor, GfK Healthcare, had the opportunity to conduct a workshop offering an updated perspective on the same topic he spoke about in 2008, i.e., “Prophesying the Form, Function and Future of Pharmaceutical Marketing Research Agencies.”

This topic, which was also the focus of the June 2008 Orange Pages module, is of obvious interest to our profession in these tumultuous times, when organizational structures and functions that have been relatively the same for decades are suddenly undergoing significant change. 

This month’s published document for The Orange Pages summarizes the comparison of Dr. Vanderveer’s 2008 predictions with 2010 realities.

Distressed pharma business models, an economy stuck in the mud and changing technologies boosting patients’ knowledge and researchers’ capabilities challenged marketing research in the pharmaceutical, health care, life science and medical device industries in 2010. 

What’s ahead in 2011? Three GfK Healthcare experts, along with other marketing research agency leaders, offer their predictions to Pharma Market Research Report.

Click here to read the issue, which includes:

• A Marketing Research Project Begging to Be Done – And Important Insights Waiting to Be Gained
• GfK Healthcare Researchers Featured in MM&M's Pipeline 2011
• The Growing Importance of “Patient Experience”

Pipeline archive is available. Skim the directory and select articles you missed. Access subscriber opt-in/comment form.